Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort
Abstract Background Non-steroidal anti-inflammatory drugs (NSAID) are frequently used to treat pain, fever and inflammatory conditions. Due to evidenced fetotoxicity, treatment with NSAID and metamizole should be avoided in the 3rd trimester of pregnancy. There is an ongoing debate on fetotoxic risk...
Saved in:
Main Authors: | Katarina Dathe (Author), Johanna Frank (Author), Stephanie Padberg (Author), Stefanie Hultzsch (Author), Evelin Beck (Author), Christof Schaefer (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection of Thalidomide Embryotoxicity by In Vitro Embryotoxicity Testing Based on Human iPS Cells
by: Nobuo Aikawa, et al.
Published: (2014) -
Parenteral Ready-to-Use Fixed-Dose Combinations Including NSAIDs with Paracetamol or Metamizole for Multimodal Analgesia-Approved Products and Challenges
by: Fernando Silva, et al.
Published: (2023) -
Comparison Characteristics of Family and Demographic of Children with Antenatal Hydronephrosis between 2nd and 3rd Trimesters of Gestation
by: Maryam NAZEMIPOUR, et al.
Published: (2018) -
Development of technique for in vitro embryotoxicity of dental biomaterials
by: Koichi Imai, D.D.S., Ph.D
Published: (2016) -
Embryotoxicity assays for leached components from dental restorative materials
by: Mummolo Stefano, et al.
Published: (2011)